We are live on ! Find out more
SRIM

Saratoga Research & Investment Management Portfolio holdings

AUM $1.83B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+2.94%
1 Year Est. Return
+18.41%
3 Year Est. Return
+54.35%
5 Year Est. Return
+69.05%
10 Year Est. Return
+285.04%
AUM
$1.17B
AUM Growth
+$53.5M
Cap. Flow
+$32.6M
Cap. Flow %
2.79%
Top 10 Hldgs %
51.11%
Holding
46
New
–
Increased
16
Reduced
26
Closed
1

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$19.9M
2
CTSH icon
Cognizant
CTSH
+$11M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$3.38M
4
EXPD icon
Expeditors International
EXPD
+$2.96M
5
AAPL icon
Apple
AAPL
+$2.58M

Top Sells

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$5.29M
2
PEP icon
PepsiCo
PEP
+$4.14M
3
MDT icon
Medtronic
MDT
+$1.9M
4
BDX icon
Becton Dickinson
BDX
+$1.74M
5
ACN icon
Accenture
ACN
+$1.48M

Sector Composition

Rank Sector Weight
1 Technology 32.35%
2 Consumer Staples 18.2%
3 Healthcare 17.67%
4 Industrials 16.08%
5 Consumer Discretionary 4.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.45T
$76.8M 6.58%
2,717,180
+97,340
+4% +$2.58M
MSFT icon
2
Microsoft
MSFT
$3.74T
$71.5M 6.12%
1,241,665
-1,417
-0.1% -$80K
WMT icon
3
Walmart Inc
WMT
$901B
$64.6M 5.53%
2,686,179
+33,168
+1% +$805K
ORCL icon
4
Oracle
ORCL
$419B
$63.9M 5.47%
1,626,558
+57,565
+4% +$2.35M
CSCO icon
5
Cisco
CSCO
$475B
$62.3M 5.33%
1,963,510
+25,655
+1% +$789K
RTX icon
6
RTX Corp
RTX
$302B
$59M 5.05%
922,912
+37,690
+4% +$2.5M
PG icon
7
Procter & Gamble
PG
$338B
$51.4M 4.4%
572,980
-1,727
-0.3% -$150K
NVO
8
Novo Nordisk
NVO
$207B
$49.9M 4.27%
2,397,398
+802,534
+50% +$19.9M
CHRW icon
9
C.H. Robinson
CHRW
$17B
$48.9M 4.19%
694,285
+18,950
+3% +$1.33M
VAR
10
DELISTED
Varian Medical Systems, Inc.
VAR
$48.6M 4.17%
557,362
+18,215
+3% +$1.49M
BRK.B icon
11
Berkshire Hathaway Class B
BRK.B
$1.11T
$48.2M 4.12%
333,477
+23,106
+7% +$3.38M
BDX icon
12
Becton Dickinson
BDX
$49.4B
$43.6M 3.74%
248,817
-10,160
-4% -$1.74M
MDT icon
13
Medtronic
MDT
$116B
$38.8M 3.32%
448,833
-21,833
-5% -$1.9M
BIIB icon
14
Biogen
BIIB
$30.1B
$38.4M 3.29%
122,572
+3,237
+3% +$959K
ACN icon
15
Accenture
ACN
$110B
$36.8M 3.15%
301,167
-12,984
-4% -$1.48M
JNJ icon
16
Johnson & Johnson
JNJ
$626B
$34.8M 2.98%
294,759
-8,267
-3% -$1M
IBM icon
17
IBM
IBM
$225B
$34.8M 2.98%
229,033
+3,348
+1% +$508K
KO icon
18
Coca-Cola
KO
$372B
$34.1M 2.92%
806,244
-28,458
-3% -$1.25M
MMM icon
19
3M
MMM
$94.4B
$34M 2.91%
230,853
-8,424
-4% -$1.26M
PEP icon
20
PepsiCo
PEP
$189B
$32.9M 2.81%
302,182
-38,452
-11% -$4.14M
CTSH icon
21
Cognizant
CTSH
$26.4B
$30.9M 2.65%
648,697
+193,530
+43% +$11M
SYY icon
22
Sysco
SYY
$40.3B
$28.6M 2.45%
584,442
-13,621
-2% -$700K
EXPD icon
23
Expeditors International
EXPD
$23B
$28.2M 2.42%
548,042
+58,437
+12% +$2.96M
PII icon
24
Polaris
PII
$3.99B
$24.9M 2.13%
321,606
+111
+0% +$9.64K
NKE icon
25
Nike
NKE
$61.3B
$22.7M 1.94%
430,468
-8,902
-2% -$503K
1
2

Similar funds

SI
Standard Investments New York $1.83B AUM 4.12% 1-Year Est. Return
KAM
Kensington Asset Management Austin, Texas $1.84B AUM 13.95% 1-Year Est. Return
DWT
Dorsey & Whitney Trust Sioux Falls, South Dakota $1.82B AUM 19.69% 1-Year Est. Return
OQS
Occudo Quantitative Strategies Fort Lauderdale, Florida $1.84B AUM 22.15% 1-Year Est. Return
RP
Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
ABTD
Arvest Bank Trust Division Dewey, Oklahoma $1.84B AUM 20.84% 1-Year Est. Return
FCIM
Fairview Capital Investment Management Greenbrae, California $1.84B AUM 13.39% 1-Year Est. Return

Saratoga Research & Investment Management's Q3 2016 Portfolio in Review

As of Q3 2016, Saratoga Research & Investment Management held 46 positions worth $1.17B, up 4.8% from $1.11B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Trading was light in Q3 2016: portfolio turnover was 2.2%. Saratoga Research & Investment Management opened no new positions and exited 1, leaving the 46-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Saratoga Research & Investment Management added most to Novo Nordisk in Q3 2016, an estimated $19.9M increase.
  • Saratoga Research & Investment Management's biggest Q3 2016 reduction was PepsiCo, cutting an estimated $4.14M.
  • Saratoga Research & Investment Management fully exited Colgate-Palmolive in Q3 2016, selling an estimated $5.29M.
  • Saratoga Research & Investment Management's ten largest holdings make up 51% of its $1.17B portfolio in Q3 2016.
  • Saratoga Research & Investment Management opened 0 new positions and closed 1 in Q3 2016.
  • Saratoga Research & Investment Management's portfolio value rose 4.8% quarter-over-quarter to $1.17B.

Based on Saratoga Research & Investment Management's 13F filing for Q3 2016, filed 2 Nov 2016.